These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 3566304)

  • 1. [Phase II study of a new nitrosourea derivative, MCNU, in tablet form. Takai Blood Cancer Study Group].
    Kobayashi T; Tanaka I; Shirakawa S; Fujiwara Y; Hirota Y; Kobayashi M; Ohno R; Yamada H; Mitomo Y; Yamamoto M
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1079-85. PubMed ID: 3566304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Phase II study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Tanaka I; Kobayashi T; Shirakawa S; Ikeda Y; Kobayashi M; Yamagata K; Ohta K; Ohno R; Yamada H; Yamada K
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):493-8. PubMed ID: 3859248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Phase II study on oral administration of MCNU (ranomustine) tablet. Hanshin Cooperative Study Group on Hematological Disorders].
    Kanamaru A; Nagai K; Masaoka T; Shibata H; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M
    Gan To Kagaku Ryoho; 1986 May; 13(5):1915-20. PubMed ID: 3458432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Phase I study on oral administration of methyl-6-[[[(2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU)].
    Kanamaru A; Nagai K; Fujita S; Masaoka T; Takubo T; Kitani T; Taniguchi N; Horiuchi A; Tsubaki K; Kawagoe H; Hirata M; Yonezawa T; Tsubakio T; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A
    Gan To Kagaku Ryoho; 1983 Aug; 10(8):1831-7. PubMed ID: 6882006
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Phase II study with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
    Higuchi A; Miyazaki T; Sakurada K; Morioka M; Musashi M; Imamura M; Maekawa I; Saitoh H; Ohtani N; Kasai M
    Gan To Kagaku Ryoho; 1985 Jun; 12(6):1253-9. PubMed ID: 3859250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
    Niimoto M; Yoshinaka K; Hattori T; Kobayashi S; Hosoma S; Ogawa Y; Iwamori S; Nagata N; Yamagata S; Nishimawari K
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
    Tatsumi N; Yamada K; Ohshima T; Nakamura T; Ohno R; Masaoka T; Kimura I; Kimura K
    Gan To Kagaku Ryoho; 1990 Dec; 17(12):2387-95. PubMed ID: 2260876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A phase II study of ranomustine (MCNU) tablets in patients with gastrointestinal cancer--by cooperative study group].
    Taguchi T
    Gan To Kagaku Ryoho; 1984 Nov; 11(11):2420-6. PubMed ID: 6497400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic effect of ranimustine(MCNU) on myeloproliferative disorder and chronic myelomonocytic leukemia].
    Maeda S; Okabe M; Kurosawa M; Kunieda Y; Imamura M; Morioka M; Sakurada K; Miyazaki T; Sukegawa M
    Gan To Kagaku Ryoho; 1991 Feb; 18(2):251-8. PubMed ID: 1992919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ranimustine].
    Masaoka T
    Gan To Kagaku Ryoho; 1990 Feb; 17(2):301-7. PubMed ID: 2405779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase I study of 1-(2-chloroethyl)-3-isobutyl-3-(beta-maltosyl)-1-nitrosourea (TA-077). Phase I Study Group].
    Gan To Kagaku Ryoho; 1986 Jul; 13(7):2425-33. PubMed ID: 3729497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
    Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
    Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new nitrosourea derivative for the treatment of chronic myelogenous leukemia.
    Hiraoka A; Masaoka T; Shibata H; Miyazaki T; Nakamura T; Yasunaga K; Kitani T; Yonezawa T; Kawagoe H; Horiuchi A
    Leuk Res; 1988; 12(6):487-90. PubMed ID: 3043111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapeutic effect of ranimustine (MCNU) on essential thrombocythemia and polycythemia vera].
    Nagai M; Tasaka T; Kamano H; Ohnishi H; Taoka T; Ikeda K; Kubota Y; Tanaka T; Irino S
    Gan To Kagaku Ryoho; 1988 Dec; 15(12):3267-70. PubMed ID: 3196045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
    Masaoka T; Kimura K; Miyazaki T; Hirota Y; Nakamura T; Yasunaga K; Ohkubo H; Okamoto Y; Fujitake H; Kitani T
    Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I clinical study of the new amino acid-linked nitrosourea, S 10036, administered on a weekly schedule.
    Khayat D; Lokiec F; Bizzari JP; Weil M; Meeus L; Sellami M; Rouesse J; Banzet P; Jacquillat C
    Cancer Res; 1987 Dec; 47(24 Pt 1):6782-5. PubMed ID: 3677107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Phase II study with methyl-6[[[2-chloroethyl) nitrosoamino] carbonyl] amino]-6-deoxy-alpha-D-glucopyranoside (MCNU) in hematological malignancies].
    Masaoka T; Kimura K; Miyazaki T; Sakurada K; Saitoh H; Morioka M; Fujimoto N; Musashi M; Wakui A; Yokoyama M; Kanamaru R; Oguro M; Takagi T; Konda C; Saitoh T; Nakao I; Harashima S; Ohhashi Y; Sakai Y; Sasaki T; Ohno R; Katoh Y; Yamada K; Hirota Y; Takada T; Hoshino A; Ohara K; Kamiya O; Kojima T; Nagata K; Nakamura T; Sasada M; Yonezawa T; Tsubakio T; Kanayama Y; Kitani T; Taniguchi N; Yasunaga K; Okamoto Y; Fujitake H; Ohkubo A; Horiuchi A; Tsubaki K; Takubo T; Shibata H; Kawagoe H; Hirata M; Matsubuchi T; Nagai K; Fujita S
    Gan To Kagaku Ryoho; 1983 Jun; 10(6):1518-23. PubMed ID: 6347081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A phase II study of N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PL-AC) in patients with acute leukemia and myelodysplastic syndromes. Cooperative Study Group for PL-AC].
    Kimura K
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2475-81. PubMed ID: 3619459
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Approval summary for imatinib mesylate capsules in the treatment of chronic myelogenous leukemia.
    Cohen MH; Williams G; Johnson JR; Duan J; Gobburu J; Rahman A; Benson K; Leighton J; Kim SK; Wood R; Rothmann M; Chen G; U KM; Staten AM; Pazdur R
    Clin Cancer Res; 2002 May; 8(5):935-42. PubMed ID: 12006504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prolonged remission in a patient with chronic myelocytic leukemia (CML) by methyl 6-[3-(2-chloroethyl)-3-deoxy-alpha-D-glucopyranoside (MCNU)].
    Murase T; Nagura E; Ohno R
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 1):2590-3. PubMed ID: 6594976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.